CAPE TOWN, South Africa — A biochemical test that can rapidly identify extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a blood culture is 100% accurate on all fronts, new ...

Travelers to areas like Latin America, Africa and South and Southeast Asia often carry antibiotics in case of infection, but treating diarrhea with those antibiotics can leave travelers at great risk ...

Every year, millions of travellers visit countries with poor hygiene, and approximately one third of them return home carrying antibiotic-resistant ESBL intestinal bacteria. Most of them remain ...

Illustration of Enterobacteriaceae bacteria. Individual bacterium are shown as pink rod shapes. The Enterobacteriaceae family contains over a hundred species including Shigella, Klebsiella, Salmonella ...

Food chain monitoring in Finland has found a low level of an indicator of antimicrobial resistance (AMR) in meat and animals, according to recent review of data. Extended-spectrum beta-lactamases ...

This retrospective case series was conducted at a 1242-bed academic medical institution located in Columbus, OH. The SOT program was established in 1967. The transplant program maintains an electronic ...

In a study to identify risk factors and outcomes in extended-spectrum beta-lactamose-producing Enterobacteriaceae infections in pediatric patients, researchers found 77 percent of the infections were ...

ESBL bacteria make beta-lactamase enzymes, which promote resistance to certain broad-spectrum antibiotics. The researchers found that L. parafarraginis, a gram-positive microbe, produced a substance, ...

The emergence of antibiotic resistance among dangerous pathogens is increasingly problematic worldwide. Many strains of infectious bacteria have become multidrug-resistant, and cannot be treated with ...

**Note this is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2021). Please credit the conference if you use this story** New research being ...

An international study comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, ...